| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5a6c77a1effd2f669e387c464babaccc |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P19-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1241
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y207-07001 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-19 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-54 |
| filingDate |
2020-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_251be9e18150172051cded5511c3cba2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85cfdaaa496e096da4a21d45a3f922d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8de3d279a3a9bd32bca0b297ee9d7d84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af8faf39ba386f912465dc384a28bb82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1de8a430f1b21008401708c1cfbffbbb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f30a6723267d524ab80b89058e395aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f4f58bcc5d8d80ea7bb426eba885fcd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f04c15eec0e16265fd02a1873a09282 |
| publicationDate |
2021-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-112574970-A |
| titleOfInvention |
A kind of nicotinamide mononucleotide adenosyltransferase mutant and its application |
| abstract |
The present invention provides a nicotinamide mononucleotide adenosyltransferase mutant and its application. The nicotinamide mononucleotide adenosyltransferase mutant has the amino acid sequence shown in SEQ ID NO. amino acid sequence, and it has nicotinamide mononucleotide adenosyltransferase activity. In the present invention, the site of nicotinamide mononucleotide adenosyl transferase is screened, and the site related to catalysis is mutated at a site to obtain a mutant with higher enzymatic activity, which can improve nicotinamide adenine dinucleotide yield and reduce the production cost of nicotinamide adenine dinucleotide. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113106080-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114426959-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113106080-B |
| priorityDate |
2020-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |